• SENSEX 81,087.69
    -97.89 (--0.12%)
  • BANKNIFTY 55,617.60
    -344.35 (--0.62%)
  • Tata Motors
    647.20 542.55(%)
  • Axis Bank
    1,060.20 934.00(%)
  • Vimta Labs
    677.30 235.00(%)
  • GE Vernova T&D
    2,871.15 2,871.15(%)
  • Netweb Technol.
    2,299.15 3,060.00(%)
  • Suzlon Energy
    66.80 86.04(%)
  • Kaynes Tech
    6,483.00 7,824.95(%)
  • M & M
    3,117.25 2,360.45(%)
  • PNB Housing
    803.30 746.10(%)
  • Waaree Energies
    3,163.55 3,740.75(%)
  • HDFC Bank
    2,010.00 1,593.20(%)
  • Jayaswal Neco
    48.32 26.06(%)
  • Skipper
    548.00 665.00(%)
  • Shree Refrigerat
    177.70 177.70(%)
  • Timex Group
    244.75 289.90(%)
  • Hind. Unilever
    2,728.10 3,034.50(%)
  • TCS
    3,000.00 3,000.00(%)
  • Ceinsys Tech
    1,750.85 538.20(%)
  • Swiggy
    386.25 297.00(%)
  • KIOCL
    374.20 461.35(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Vaishali Pharma Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 71078.0
  • ISIN : INE972X01022
12.70 0 (2.92%)
  • As on 02 Aug 2025 (EOD)

  • Today’s Low

    12.24

  • Today’s High

    13.10

  • Open

    12.26

  • Perv Close

    12.34

  • 52W Low

    10.30

  • 52W High

    24.91

Key Indicators

  • P/E(TTM)

    158.75

  • Mar.Cap (₹Cr.)

    136.13

  • Div & Yield %

    0.00

  • Book Value(₹)

    5.62

  • Debt-Equity Ratio

    2.92

  • AGM Date

    01-Aug-2025

  • EPS

    0.08

  • P/E Ratio

    158.75

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    136.13

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    21.44

  • BV (₹)

    5.60

  • Sales( ₹ in Cr.)

    99.03

  • NP (in Cr.)

    0.82

  • NP Var(%)

    14.0

  • Div%

    0.0

  • CPS (₹)

    0.10

  • EPS (₹)

    0.10

  • Traded Value (₹ in Lakhs)

    136.13

  • 52 Week High

    24.91

  • 52 Week Low

    10.30

  • Price BSE

    0.0

  • Price NSE

    13.00

  • Market Capital( in Cr.)

    136.13

  • P/C Ratio

    106.90

  • P/E Ratio

    170.50

  • Price Vs.BV

    0.10

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 86.28 69.66 75.82 53.77 60.09 75.09
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 86.28 69.66 75.82 53.77 60.09 75.09
Other Income 2.03 2.23 1.79 1.81 2.17 1.98
Stock Adjustments -2.67 2.42 0.04 -0.29 -0.10 -0.89
Total Income 85.64 74.31 77.65 55.29 62.16 76.18
EXPENDITURE :            
Raw Materials 71.75 57.10 63.54 45.86 50.99 67.78
Power and Fuel Cost 0.00 0.00 0.00 0.00 0.00 0.00
Employee Cost 1.40 1.30 1.36 1.19 1.27 2.13
Other Manufacturing Expenses 0.02 0.02 0.02 0.02 0.02 0.03
Selling and Administration Expenses 3.44 4.28 4.06 1.94 2.62 2.15
Miscellaneous Expenses 5.33 0.00 0.00 1.82 4.19 0.04
Employee Benefit Expenses 1.40 1.30 1.36 1.19 1.27 2.13
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 81.95 62.71 68.97 50.83 59.09 72.13
Operating Profit 3.70 11.61 8.67 4.46 3.08 4.06
Interest 2.27 2.26 2.49 2.63 2.56 2.66
Gross Profit 1.43 9.35 6.18 1.83 0.52 1.40
Depreciation 0.51 0.50 0.46 0.43 0.44 0.27
Profit Before Tax 0.92 8.85 5.72 1.40 0.08 1.13
Current Tax 0.25 2.24 1.72 0.38 0.06 0.45
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.04 0.00 -0.02 -0.02 -0.01 -0.03
Reported Net Profit 0.72 6.60 4.02 1.05 0.03 0.71
Extraordinary Items 0.00 0.00 0.00 0.00 0.00 0.00
Adjusted Net Profit 0.72 6.60 4.02 1.05 0.03 0.71
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 14.19 7.59 3.57 2.52 2.49 1.77
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down 14.91 14.19 7.59 3.57 2.52 2.49
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 0.67 6.26 3.82 0.99 0.03 1.08
Earnings Per Share(Adj)-Unit Curr 0.67 6.26 3.82 0.99 0.03 0.68
Book Value 39.97 38.43 24.99 21.26 20.27 32.47
Book Value(Adj)-Unit Curr 39.97 38.43 24.99 21.26 20.27 20.30

Shareholding Pattern

  • Promoter Group

    26.32%

  • Public Share Holding

    73.68%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 50 0.00 50 5
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 28,215,240 26.32 28,215,240 5
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 28,215,290 26.32 28,215,290 10
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 968 0.00 968 2
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 968 0.00 968 2
2] Non Institution
Bodies Corporate 4,982,296 4.65 4,982,296 46
Clearing Members 330,597 0.31 330,597 14
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 474,378 0.44 474,378 167
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 2,567,292 2.40 2,567,292 338
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 34,343,958 32.04 34,343,958 76
Individuals holding nominal share capital up to Rs. 1 lakh 36,272,621 33.84 36,272,621 28,028
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 78,975,872 73.68 78,975,872 28,670
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 107,192,130 100.00 107,192,130 28,682

Company Background

Vaishali Pharma LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Vaishali Pharma Ltd
  • BSE Code : 71078.0
  • ISIN : INE972X01022

  • Incorporation Year

    2008

  • Registered Office

    706 to 709 7th Floor Aravali
    Business Centre Borivali(W), Mumbai,
    Maharashtra-400092

  • Telephone

    91-22-28928833

  • FAX

    91-22-28928833

  • Chairman

    Atul Vasani

  • Managing Director

    Atul Vasani

  • Company Secretary

    Vishwa Mekhia

  • Auditor

    Raman S Shah & Associates

  • Face Value

    2

  • Listing

    NSE

  • Registrar

    Bigshare Services Pvt Ltd
    Office No 56-2 ,
    Pinnacle Busine.Park,Mahakali Caves Road
    Mumbai - Mumbai - 400093

Vaishali Pharma Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Vaishali Pharma 12.70 88.31 86.28 158.75 5.71
Abbott India 33,676.00 6,684.73 6,409.15 50.59 44.95
Astrazeneca Phar 8,893.15 1,756.92 1,716.29 192.08 32.94
P & G Health Ltd 6,199.70 1,166.89 1,151.26 40.97 39.76
Glaxosmi. Pharma 2,933.90 3,866.05 3,723.49 52.76 58.72
Cipla 1,501.20 20,029.57 19,044.85 22.44 21.40
Amrutanjan Healt 676.35 437.58 421.23 38.47 20.84
Guj. Themis Bio. 371.85 174.19 169.82 90.92 44.82
Fermenta Biotec. 362.00 442.21 430.53 15.76 17.61
Bliss GVS Pharma 173.70 703.42 667.20 25.96 9.16
Ambalal Sarabhai 32.97 19.33 4.04 30.53 2.10